Centrient Pharmaceuticals is a Manufacturer/Innovator company operating in the pharmaceutical industry.
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs). First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,200-people strong with operations on four continents.
Company type
Manufacturer/Innovator
Products and services
Intermediates, Fine and Specialty Chemicals, Finished Dosage Forms, Pharmaceutical Packaging, APIs (Active Pharmaceutical Ingredients)
Markets
North America (USA, Canada), Africa, Central America (e.g. Mexico), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Centrient Pharmaceuticals on LinkedIn
Address
Centrient Pharmaceuticals, Sir Winston Churchilllaan 299, Rijswijk, Netherlands, 2288 DC
